Search

Displaying results 9641 - 9650 of 10000 in total
  1. Drug

    Envonalkib

    go.drugbank.com/drugs/DB21585
    Experimental

    Envonalkib is a small molecule drug. The usage of the INN stem '-alkib' in the name indicates that Envonalkib is a ALK (anaplastic lymphoma kinase) inhibitor.

  2. Drug

    Zurletrectinib

    go.drugbank.com/drugs/DB21601
    Experimental

    Zurletrectinib is a small molecule drug. The usage of the INN stem '-trectinib' in the name indicates that Zurletrectinib is a tropomyosin receptor kinase (TRK) inhibitor.

  3. Drug

    Rolusafine

    go.drugbank.com/drugs/DB21617
    Experimental

    Rolusafine is a small molecule drug. The usage of the INN stem '-afine' in the name indicates that Rolusafine is a antifungal squalene mono-oxygenase inhibitor.

  4. Drug

    Merigolix

    go.drugbank.com/drugs/DB21628
    Experimental

    Merigolix is a small molecule drug. The usage of the INN stem '-golix' in the name indicates that Merigolix is a gonadotropin releasing hormone (GnRH) antagonist.

  5. Drug

    Lerzeparib

    go.drugbank.com/drugs/DB21650
    Experimental

    Lerzeparib is a small molecule drug. The usage of the INN stem '-parib' in the name indicates that Lerzeparib is a poly-ADP-Ribose polymerase inhibitor.

  6. Drug

    Nurandociguat

    go.drugbank.com/drugs/DB21720
    Investigational

    Nurandociguat is a small molecule drug. The usage of the INN stem '-ciguat' in the name indicates that Nurandociguat is a guanylate cyclase activator and stimulator.

  7. Drug

    Talogreptide mesaroxetan

    go.drugbank.com/drugs/DB21743
    Experimental

    Talogreptide mesaroxetan is a small molecule drug. The usage of the INN stem '-xetan' in the name indicates that Talogreptide mesaroxetan is a chelating agent.

  8. Drug

    Fiztasovimab

    go.drugbank.com/drugs/DB24033
    Investigational

    [A278004, A278005] NPC-21 is under investigation in clinical trial NCT04225923 (A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection). … Fiztasovimab, also known as NPC‐21 and EV2038, is a monoclonal antibody.

  9. Drug

    PF-06273340

    go.drugbank.com/drugs/DB12269
    Investigational

    Pf 06273340 is under investigation in clinical trial NCT01934738 (A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects

  10. Drug

    Zelenirstat

    go.drugbank.com/drugs/DB15567
    Investigational

    Zelenirstat (PCLX-001) is a first-in-kind N-Myristoyltransferase (NMT) inhibitor being developed by [Pacylex Pharmaceuticals](https://pacylex.com). … Current studies have shown that zelenirstat works differently than other known cancer drugs and has high activity and positive results in breast, lung, bladder and pancreas cancers.[L9470]

    Synonyms: 2,6-Dichloro-N-(3-isobutyl-1,5-dimethyl-1H-pyrazol-4-yl)-4-(2-(piperazin-1-yl)pyridin-4-yl)benzenesulfonamide, 2,6-Dichloro-N-(1,5-dimethyl-3-(2-methylpropyl)-1H-pyrazol-4-yl)-4-(2-(1-piperazinyl)-4-pyridinyl)benzenesulfonamide